However, HAART has not reduced the incidence of non-AIDS defining cancers such as anal cancer. One theory is that immunosuppression plays a role in the development of anal cancer. It has been suggested that immunosuppression not only leads to increased risk of non AIDS defining cancers but also increases the aggressive nature of such Inhibitors,research,lifescience,medical cancers (7). A
French study examined the incidence of cancer in a cohort of HIV+ patients and found that a CD4 count less than 200 cells per uL and HIV viral load >100,000 copies per mL were associated with an increased risk of anal cancer. The majority of patients (93%) diagnosed with anal cancer had been treated with antiretroviral therapy for over 6 months (12). Screening Anal cancer and cervical cancer share many similar characteristics. Both anal cancer and cervical cancer develop from precursor lesions: anal intraepithelial neoplasia (AIN) and cervical intraepithelial neoplasia (CIN) respectively. The incidence and mortality from cervical cancer in the U.S. has significantly Inhibitors,research,lifescience,medical diminished with the routine use of cytology screening with the Inhibitors,research,lifescience,medical Papanicolau (Pap) smear test. Pap smears identify precancerous lesions and early treatment of these lesions has been shown to prevent the development of cervical cancer. As a result the rate of cervical cancer dramatically decreased in the U.S. In countries
where screening for cervical cancer is not routinely done the incidence and mortality of cervical cancer is much greater. Squamous cell carcinoma of the anus is thought to arise from a precancerous lesion. The etiology of
this precancerous lesion is Inhibitors,research,lifescience,medical thought to involve integration of HPV into the patient’s genome. Similar to cervical cancer, a Bethesda staging criteria has been devised for precursor anal lesions (13). AIN1 is thought to be low grade squamous intraepithelial lesion (LSIL) whereas AIN 2, 3 are high grade squamous intraepithelial lesion (HSIL). Similar to cervical cancer, Inhibitors,research,lifescience,medical treatment is recommended for high grade precancerous (HSIL) anal lesions. Studies have identified additional risk factors in the development of AIN. to Wilkin et al (2004) studied the risk of developing AIN in HIV+ men (14). Almost three-quarters of men with abnormal anal cytology had co-infection with a high risk HPV serotype (HPV 16>>52>18>45) (14). Multivariate AZD8055 solubility dmso analysis indicated that abnormal cytology was more likely in patients with a history of RAI and no HAART treatment. AIN histology on biopsy was more likely in patients with history of RAI, history of no HAART use, young age (<40) and low CD4 count (<350). CD4 count was the most significant prognostic factor. Patient who were on HAART and had persistent low CD4 counts were also more likely to have AIN. The relationship between AIN and HAART use, CD4 count, and viral load is probably confounded as patients with lower CD4 counts are more likely to have high viral loads and to be started on HAART.